Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-29109167

RESUMO

Nine aph genes, including aph(2″)-Ib, aph(2″)-Ic, aph(2″)-Ig, aph(2″)-If, aph(2″)-If1, aph(2″)-If3, aph(2″)-Ih, aac(6')-Ie-aph(2″)-Ia, and aac(6')-Ie-aph(2″)-If2, were previously identified in Campylobacter To measure the contribution of these alleles to aminoglycoside resistance, we cloned nine genes into the pBluescript and expressed them in Escherichia coli DH5α. The nine aph expressed in E. coli showed various levels of resistance to gentamicin, kanamycin, and tobramycin. Three genes, aac(6″)-Ie-aph(2″)-Ia, aph2″-If1, and aph2″-Ig, showed increased MICs to amikacin, and five aph genes were transferrable.


Assuntos
Aminoglicosídeos/farmacologia , Antibacterianos/farmacologia , Campylobacter/enzimologia , Campylobacter/genética , Farmacorresistência Bacteriana/genética , Canamicina Quinase/genética , Campylobacter/efeitos dos fármacos , Clonagem Molecular , Conjugação Genética , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Regulação Bacteriana da Expressão Gênica/efeitos dos fármacos , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Canamicina Quinase/biossíntese , Testes de Sensibilidade Microbiana
2.
Appl Microbiol Biotechnol ; 86(2): 671-9, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19936737

RESUMO

ColE1-like plasmids are widely used as expression vectors and as gene delivery vehicles. We have recently described a naturally occurring plasmid deletion phenomenon in the ColE1-type plasmid, pCI-neo, which leads to the detectable expression of an apparently promotorless kanamycin resistance gene. In the current work, we found that the expression of that aminoglycoside phosphotransferase (aph) gene is regulated by an RNAII preprimer promoter located within the plasmid ColE1 replication origin, as a consequence of the extension of the RNA II species for at least 1.5 kb, up to the aph gene. This mechanism is dependent on the nonformation and/or dissociation of the hybrid between plasmid DNA and RNA II preprimer transcript. This is the first in vivo description of RNA II transcription beyond ori in wild-type Escherichia coli strains and nonmutated RNAII plasmid sequences resulting in productive transcription of distant downstream genes. Our results raise questions about unwanted expression of genes from expression or cloning vectors of ColE1 type and highlight the importance of a more careful design of ColE1-derived plasmid vectors.


Assuntos
Proteínas de Escherichia coli/biossíntese , Escherichia coli/genética , Expressão Gênica , Canamicina Quinase/biossíntese , Plasmídeos , Origem de Replicação , Proteínas de Escherichia coli/genética , Perfilação da Expressão Gênica , Canamicina Quinase/genética , Deleção de Sequência
3.
Mitochondrion ; 8(5-6): 345-51, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18721905

RESUMO

Transformation of mitochondria in mammalian cells is now a technical challenge. In this report, we demonstrate that the standard drug resistant genes encoding neomycin and hygromycin phosphotransferases can potentially be used as selectable markers for mammalian mitochondrial transformation. We re-engineered the drug resistance genes to express proteins targeted to the mitochondrial matrix and confirmed the location of the proteins in the cells by fusing them with GFP and by Western blot and mitochondrial content mixing analyses. We found that the mitochondrially targeted-drug resistance proteins confer resistance to high levels of G418 and hygromycin without affecting the viability of cells.


Assuntos
Resistência a Medicamentos , Canamicina Quinase/biossíntese , Mitocôndrias/metabolismo , Fosfotransferases (Aceptor do Grupo Álcool)/biossíntese , Proliferação de Células , Cinamatos/farmacologia , Gentamicinas/farmacologia , Células HeLa , Humanos , Higromicina B/análogos & derivados , Higromicina B/farmacologia , Proteínas Recombinantes de Fusão/biossíntese
4.
Mol Biol (Mosk) ; 42(6): 1030-9, 2008.
Artigo em Russo | MEDLINE | ID: mdl-19140324

RESUMO

Yeast recombinant plasmid containing FRT-sequence flanked by hybrid GAL-CYC promoter and NPTII gene was developed. GAL-CYC promoter contains four UAS sequences and two closely associated TATA-boxes in CYC part. This construct provides galactose-inducible synthesis of neomycinphosphotransferase from NPTII gene, and, thus, resistance of transformed cells to G418 antibiotic. Nucleosome positioning within NPTII gene in repressed and active states was studied. Under repressive conditions (growth on glucose) stable positioning of three nucleosomes was detected. Two nucleosomes are localized in CYC-part. One of them encompasses both TATA-boxes. The third nucleosome overlaps FRT sequence and start of NPTII gene coding sequence. All three nucleosomes show multiple positioning. It suggests possibility of nucleosome sliding along DNA. After induction of NPTII expression by galactose sliding of two nucleosomes is detected. Sliding leads to exposure of TATA-box and long promoter segment. Sliding results in stable repositioning of nucleosomes at new sites. 5'-distal nucleosome moves closer to UAS-sequences. As a results UAS becomes spatially closer to TATA-box. This proximity facilitates assembly of preinitiation complex. Nucleosomes slides independently from each other. The second nucleosome moves towards FRT-sequence and repositions at its nucleosome positioning signal. Galactose-induced expression does not affect nucleosome positioning with coding region of NPTII gene. Unidirectional sliding and repositioning are detected without induction after deacetylase inhibition with trichostatine A. Basal expression of NPTII gene was shown without activation of GAL-CYC promoter and after spatial uncoupling of coding sequence and promoter by gene inversion. In these cases it seems that expression is driven by TATA-like element in FRT-sequence. This element is located in permanently exposed area (in vivo data).


Assuntos
Canamicina Quinase/biossíntese , Nucleossomos/metabolismo , Plasmídeos/metabolismo , Elementos de Resposta/fisiologia , Saccharomyces cerevisiae/enzimologia , TATA Box/fisiologia , Amebicidas/farmacologia , Montagem e Desmontagem da Cromatina/efeitos dos fármacos , Montagem e Desmontagem da Cromatina/fisiologia , Inibidores Enzimáticos/farmacologia , Gentamicinas/farmacologia , Ácidos Hidroxâmicos/farmacologia , Canamicina Quinase/genética , Nucleossomos/genética , Plasmídeos/genética , Saccharomyces cerevisiae/genética
5.
Nat Biotechnol ; 19(3): 231-4, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11231555

RESUMO

Peptide nucleic acids (PNAs) may be a potent tool for gene function studies in medically important parasitic organisms, especially those that have not before been accessible to molecular genetic knockout approaches. One such organism is Entamoeba histolytica, the causative agent of amebiasis, which infects about 500 million people and is the cause of clinical disease in over 40 million each year, mainly in the tropical and subtropical world. We used PNA antisense oligomers to inhibit expression of an episomally expressed gene (neomycin phosphorotransferase, NPT) and a chromosomal gene (EhErd2, a homolog of Erd2, a marker of the Golgi system in eukaryotic cells) in axenically cultured trophozoites of E. histolytica. Measurement of NPT enzyme activity and EhErd2 protein levels, as well as measurement of cellular proliferation, revealed specific decreases in expression of the target genes, and concomitant inhibition of cell growth, in trophozoites treated with micromolar concentrations of unmodified antisense PNA oligomers.


Assuntos
Elementos Antissenso (Genética)/farmacologia , Regulação para Baixo/efeitos dos fármacos , Entamoeba histolytica/efeitos dos fármacos , Canamicina Quinase/metabolismo , Ácidos Nucleicos Peptídicos/farmacologia , Animais , Elementos Antissenso (Genética)/genética , Biomarcadores/análise , Divisão Celular/efeitos dos fármacos , Entamoeba histolytica/enzimologia , Entamoeba histolytica/genética , Entamoeba histolytica/crescimento & desenvolvimento , Gentamicinas/farmacologia , Complexo de Golgi/efeitos dos fármacos , Complexo de Golgi/metabolismo , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Proteínas de Membrana/biossíntese , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Microscopia de Fluorescência , Neomicina/metabolismo , Ácidos Nucleicos Peptídicos/genética , Permeabilidade , Transfecção
6.
Genetika ; 43(7): 1002-5, 2007 Jul.
Artigo em Russo | MEDLINE | ID: mdl-17899821

RESUMO

Complementary DNA for the extracellular RNase of Zinnia elegans was cloned under control of the cauliflower mosaic virus 35S RNA constitutive promoter and transferred into the Nicotiana tabacum SR1 plants. Primary tobacco transformants were characterized by a high level of RNase activity.


Assuntos
Asteraceae/enzimologia , Líquido Extracelular/enzimologia , Nicotiana/enzimologia , Plantas Geneticamente Modificadas , Ribonucleases/biossíntese , Transformação Genética , Genes Reporter , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Ribonucleases/genética , Nicotiana/genética
7.
Nucleic Acids Res ; 32(9): 2912-24, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15155860

RESUMO

Gene trap vectors developed for genome-wide mutagenesis can be used to study factors governing the expression of exons inserted throughout the genome. For example, entrapment vectors consisting of a partial 3'-terminal exon [i.e. a neomycin resistance gene (Neo), a poly(A) site, but no 3' splice site] were typically expressed following insertion into introns, from cellular transcripts that spliced to cryptic 3' splice sites present either within the targeting vector or in the adjacent intron. A vector (U3NeoSV1) containing the wild-type Neo sequence preferentially disrupted genes that spliced in-frame to a cryptic 3' splice site in the Neo coding sequence and expressed functional neomycin phosphotransferase fusion proteins. Removal of the cryptic Neo 3' splice site did not reduce the proportion of clones with inserts in introns; rather, the fusion transcripts utilized cryptic 3' splice sites present in the adjacent intron or generated by virus integration. However, gene entrapment with U3NeoSV2 was considerably more random than with U3NeoSV1, consistent with the widespread occurrence of potential 3' splice site sequences in the introns of cellular genes. These results clarify the mechanisms of gene entrapment by U3 gene trap vectors and illustrate features of exon definition required for 3' processing and polyadenylation of cellular transcripts.


Assuntos
Íntrons , Mutagênese Insercional , Sítios de Splice de RNA , Animais , Linhagem Celular , Éxons , Vetores Genéticos , Ribonucleoproteínas Nucleares Heterogêneas Grupo C/genética , Ribonucleoproteínas Nucleares Heterogêneas Grupo C/metabolismo , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Biossíntese de Proteínas , Provírus/genética , Splicing de RNA , RNA Mensageiro/metabolismo , Proteínas Recombinantes de Fusão/biossíntese , Sequências Repetidas Terminais
8.
Artigo em Inglês | MEDLINE | ID: mdl-16961274

RESUMO

In order to establish stable high expression cell lines, the eukaryotic expression vector pIRES2EGFP and recombinant plasmid pIRES2EGFP-TIM-3 were transfected into mammalian cells CHO by Lipofectamine. The transfected cells were cultivated under selective growth medium including G418 and green fluorescent protein (GFP) positive cells were sorted by FACS. Simultaneously, growing transfectants were selected only by G418 in the medium. The GFP expression in stably transfected cells was detected by FACS. Under selective growth conditions with G418, the percentage of GFP positive cells was reduced rapidly and GFP induction was low. In contrast, the percentages of GFP positive cells were increased gradually after FACS. By 3 rounds of GFP selection, the stable high expression cell lines were established. Furthermore, using FACS analysis GFP and the target protein TIM-3 co-expression in the stable transfectants cultured in nonselective medium was detected. Theses results demonstrated that the stably transfected cell lines that express high titer of recombinant protein can be simply and fleetly obtained by using GFP and selective growth medium.


Assuntos
Proteínas de Fluorescência Verde/biossíntese , Proteínas de Membrana/biossíntese , Proteínas Recombinantes de Fusão/biossíntese , Animais , Células CHO , Separação Celular , Cricetinae , Cricetulus , Células Eucarióticas/citologia , Células Eucarióticas/metabolismo , Citometria de Fluxo , Vetores Genéticos/genética , Proteínas de Fluorescência Verde/genética , Receptor Celular 2 do Vírus da Hepatite A , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Proteínas de Membrana/genética , Plasmídeos/genética , Proteínas Recombinantes de Fusão/genética , Transfecção
9.
J Interferon Cytokine Res ; 22(7): 783-91, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12184916

RESUMO

The peripheral delivery of interferon-beta (IFN-beta) for the treatment of central nervous system (CNS) diseases is only partially effective because of the blood-brain barrier (BBB). To circumvent this problem, we evaluated the feasibility of genetically altering bone marrow cells ex vivo and using them as vehicles to transfer the IFN-beta cDNA into the mouse CNS. An IFN-beta retroviral expression vector (pLXSN-IFNbeta) was used to stably transfect PA317 cells. The supernatant from these producer cells, which expressed IFN-beta mRNA and protein, were used to infect bone marrow cells. When transplanted into irradiated mice, IFN-beta-engineered marrow cells accessed the CNS and expressed IFN-beta mRNA and protein. Marrow cells transduced with a control neomycin vector entered the brain and expressed the neomycin but not the IFN-beta gene. In the CNS, IFN-beta delivered by marrow cells induced the mRNA expression of 2',5'-oligoadenylate synthetase (2',5'-OAS), indicating biologic activity. Our findings demonstrating that bone marrow cells can serve as a delivery system for IFN-beta cDNA into the CNS could have implications for the treatment of neurologic disorders, such as multiple sclerosis (MS), viral encephalitis, and brain tumors.


Assuntos
Transplante de Medula Óssea , Encéfalo/metabolismo , Vetores Genéticos/farmacocinética , Interferon beta/genética , 2',5'-Oligoadenilato Sintetase/biossíntese , 2',5'-Oligoadenilato Sintetase/genética , Animais , Barreira Hematoencefálica , DNA Complementar/genética , Indução Enzimática , Estudos de Viabilidade , Genes Reporter , Genes Sintéticos , Terapia Genética , Interferon beta/biossíntese , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Camundongos , RNA Mensageiro/biossíntese , Proteínas Recombinantes de Fusão/biossíntese , Organismos Livres de Patógenos Específicos , Transfecção
10.
Ann N Y Acad Sci ; 861: 57-66, 1998 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-9928239

RESUMO

Gene targeting has proven to be extremely powerful in various fields of biological research. Through this technique, knockout mice lacking a particular gene and thus a particular protein, can be generated. One limitation to this technique is the fact that mice develop without the protein of interest and therefore, developmental compensations may have taken place, contributing to an observed phenotype. Inducible strategies, those which allow the timing of expression of a gene to be regulated, are currently being developed and should prove useful when applied to gene targeting technology. In order to begin to apply such new technologies to the field of gene targeting, we first created and tested several reporter constructions using the tetracycline inducible system. Here we describe the creation of several beta-galactosidase reporter constructions and the results of in vitro testing in Cos-7 cells. We then discuss future knockout strategies based upon our observations.


Assuntos
Receptores de Serotonina/fisiologia , Animais , Células COS , Regulação da Expressão Gênica , Genes Reporter , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Camundongos , Camundongos Knockout , Mutagênese Insercional , Plasmídeos , Receptores de Serotonina/deficiência , Receptores de Serotonina/genética , Proteínas Recombinantes/biossíntese , Transfecção/métodos , beta-Galactosidase/biossíntese , beta-Galactosidase/genética
11.
FEMS Microbiol Lett ; 179(1): 37-42, 1999 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-10481083

RESUMO

A mini-Tn5 transposon derivative, mini-Tn5gfp-km, has been constructed which contained a promoter-less artificial operon consisting of two open reading frames, green fluorescent protein (GFP) and neomycin phosphotransferase II (NptII). When this transposon was used to mutagenize Agrobacterium tumefaciens, all the mutants selected in the presence of kanamycin exhibited GFP expression, which could be conveniently monitored by a fluorometer. The transposon appeared to be bifunctional and could provide both selection and reporter functions. Even the mutants showing minimal levels of GFP expression were still resistant to kanamycin. This suggests that this transposon can be used to select for insertions downstream of both weak and strong promoters, as long as the insertions themselves are non-lethal. This system was used to identify A. tumefaciens genes that were upregulated in response to acidic pH. Screening only 20 colonies led to identification of two promoters that were specifically induced by low pH and one promoter that was specifically induced by acetosyringone in a minimal medium of pH 5.5.


Assuntos
Agrobacterium tumefaciens/genética , Elementos de DNA Transponíveis , Óperon , Clonagem Molecular , Escherichia coli/genética , Genes Reporter , Proteínas de Fluorescência Verde , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Proteínas Luminescentes/biossíntese , Proteínas Luminescentes/genética , Fases de Leitura Aberta , Regiões Promotoras Genéticas , Proteínas Recombinantes de Fusão/biossíntese
12.
Protoplasma ; 251(5): 1175-90, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24590594

RESUMO

In spite of the economic importance of sesame (Sesamum indicum L.) and the recent availability of its genome sequence, a high-frequency transformation protocol is still not available. The only two existing Agrobacterium-mediated transformation protocols that are available have poor transformation efficiencies of less than 2%. In the present study, we report a high-frequency, simple, and reproducible transformation protocol for sesame. Transformation was done using de-embryonated cotyledons via somatic embryogenic stages. All the critical parameters of transformation, like incubation period of explants in pre-regeneration medium prior to infection by Agrobacterium tumefaciens, cocultivation period, concentrations of acetosyringone in cocultivation medium, kanamycin concentration, and concentration of plant hormones, including 6-benzylaminopurine, have been optimized. This protocol is superior to the two existing protocols in its high regeneration and transformation efficiencies. The transformed sesame lines have been tested by PCR, RT-PCR for neomycin phosphotransferase II gene expression, and ß-glucuronidase (GUS) assay. The regeneration frequency and transformation efficiency are 57.33 and 42.66%, respectively. T0 and T1 generation transgenic plants were analyzed, and several T1 plants homozygous for the transgenes were obtained.


Assuntos
Técnicas de Transferência de Genes , Glucuronidase/genética , Canamicina Quinase/genética , Sesamum/genética , Transformação Genética , Acetofenonas/farmacologia , Agrobacterium tumefaciens/genética , Antibacterianos/farmacologia , Compostos de Benzil , Cotilédone/citologia , Resistência a Medicamentos/genética , Glucuronidase/biossíntese , Canamicina/farmacologia , Canamicina Quinase/biossíntese , Cinetina/farmacologia , Plantas Geneticamente Modificadas/genética , Purinas , Sesamum/efeitos dos fármacos
16.
Cloning Stem Cells ; 10(4): 421-8, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18800861

RESUMO

Both enhanced green fluorescence protein (EGFP) and neomycin phosphotransferase type II enzyme (NPTII) are widely used in transgenic studies, but their side effects have not been extensively investigated. In this study, we evaluated the expression profiles of the two marker genes and the relationship between their expression and organ abnormalities. Eight transgenic cloned cattle were studied, four harboring both EGFP and NPTII, and four harboring only the NPTII gene. Four age-matched cloned cattle were used as controls. EGFP and NPTII expression were measured and detected by Q-PCR, Western blot, ELISA, and RIA in heart, liver, and lungs, and the values ranged from 0.3 to 5 microg/g. The expression profiles exhibited differential or mosaic pattern between the organs, the pathologic symptoms of which were identified, but were similar to those of age-matched cloned cattle. All data indicated that the expression of EGFP and NPTII is not associated with organ abnormalities in transgenic cloned cattle.


Assuntos
Animais Geneticamente Modificados/anormalidades , Bovinos/anormalidades , Clonagem de Organismos/efeitos adversos , Proteínas de Fluorescência Verde/biossíntese , Canamicina Quinase/biossíntese , Animais , Animais Geneticamente Modificados/genética , Animais Geneticamente Modificados/metabolismo , Bovinos/genética , Bovinos/metabolismo , Expressão Gênica , Cardiopatias Congênitas/patologia , Fígado/anormalidades , Fígado/metabolismo , Fígado/patologia , Pulmão/anormalidades , Pulmão/metabolismo , Pulmão/patologia , Transgenes/genética
17.
Antimicrob Agents Chemother ; 51(2): 774-6, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17088479

RESUMO

The chromosomal gene aph(3')-IIb, encoding an aminoglycoside 3'-phosphotransferase in Pseudomonas aeruginosa, was cloned and overexpressed in Escherichia coli. The APH(3')-IIb enzyme was purified as a monomer in a two-step procedure and was shown to phosphorylate its substrates at the C-3'-OH position, with kcat/Km values of 0.4x10(4) to 36x10(4) M-1 s-1.


Assuntos
Canamicina Quinase , Pseudomonas aeruginosa/enzimologia , Proteínas de Bactérias/análise , Proteínas de Bactérias/biossíntese , Proteínas de Bactérias/genética , Regulação Bacteriana da Expressão Gênica , Regulação Enzimológica da Expressão Gênica , Canamicina Quinase/análise , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Cinética , Fosforilação , Pseudomonas aeruginosa/genética
18.
Cancer Immunol Immunother ; 54(1): 67-77, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15693141

RESUMO

To induce cytolytic immunity, dendritic cells (DCs) need to release bioactive interleukin-12 (IL-12) p70 heterodimeric molecules. To study the role of IL-12 for the generation of an anti-tumor immune response, we generated two classes of DCs. (1) DCs were initiated to secrete IL-12 by exposure to LPS/IFN-gamma for 2 h resulting, as demonstrated in vitro, in continued IL-12 release for another 24 h (termed active DCs). (2) DCs were exposed to LPS/IFN-gamma for 24 h and injected into mice at a time point when IL-12 production had ceased (termed exhausted DCs). These two classes of DCs were probed for their capacity to induce a cytolytic anti-tumor immune response in vivo in a syngeneic mouse tumor model. The mouse tumor cell line K-Balb was engineered to express neomycin phosphotransferase (NPT) as a model tumor antigen. DCs were charged with various NPT-derived antigens, including recombinant NPT protein, whole tumor cell lysate and NPT-derived synthetic peptides, and the induction of in vivo anti-tumor immunity was determined by measuring tumor growth. Only the injection of active DCs, i.e., cells that maintained the capacity to secrete IL-12, but not exhausted DCs that had lost the ability to produce IL-12, resulted in a measurable deceleration of growth of K-Balb-NPT tumors. This anti-tumor immune response was most pronounced when using recombinant protein as an antigen source, which was evident in a prophylactic as well as in a therapeutic setting. The absence of a response to parental K-Balb tumors confirmed the antigen specificity of the anti-tumor immune response. Together these data provide evidence for the unique capacity of actively IL-12 secreting DCs to trigger effective anti-tumor immunity using exogenous tumor antigens.


Assuntos
Células Dendríticas/imunologia , Terapia Genética/métodos , Imunoterapia/métodos , Interleucina-12/imunologia , Interleucina-12/metabolismo , Subunidades Proteicas/imunologia , Subunidades Proteicas/metabolismo , Animais , Antígenos de Neoplasias/biossíntese , Antígenos de Neoplasias/genética , Antígenos CD4/imunologia , Antígenos CD8/imunologia , Células Cultivadas , Células Dendríticas/efeitos dos fármacos , Células Dendríticas/transplante , Epitopos , Imunofenotipagem , Interferon gama/farmacologia , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Lipopolissacarídeos/farmacologia , Camundongos , Camundongos Endogâmicos BALB C , Fatores de Tempo
19.
Biochem Biophys Res Commun ; 248(3): 806-11, 1998 Jul 30.
Artigo em Inglês | MEDLINE | ID: mdl-9704009

RESUMO

While DNA excision by Cre-loxP homologous recombination has been exploited for mammalian genetic engineering, it has not been reported whether DNA inversion is achievable by the same mechanism in mammalian cells. To investigate whether Cre-loxP-mediated DNA inversion takes place in mammalian cells, a novel retroviral vector, NT(FF), was constructed. The vector carries a marker gene cassette consisting of the neo and tk genes linked tail-to-tail to each other and flanked by an inverted repeat of loxP sequences. In NT(FF)-transduced Rat2 cells, the marker gene cassette was inverted reversibly in a Cre-dependent manner, leading to DNA "flip-flop" associated with alternate expression of the neo and tk genes. This study provides the first example of Cre-loxP-mediated DNA inversion in mammalian cells facilitating regulation of retrovirally transduced genes, suggesting the usefulness of the system for genetic engineering.


Assuntos
Inversão Cromossômica , DNA/genética , Integrases/metabolismo , Proteínas Virais , Animais , Células Cultivadas , Genes gag , Vetores Genéticos , Integrases/biossíntese , Canamicina Quinase/biossíntese , Canamicina Quinase/genética , Vírus da Leucemia Murina de Moloney , Reação em Cadeia da Polimerase , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/metabolismo , Timidina Quinase/biossíntese , Timidina Quinase/genética , Transfecção
20.
Mol Ther ; 3(5 Pt 1): 801-8, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11356085

RESUMO

Current methods to detect transduction efficiency during the routine use of integrating retroviral vectors in gene therapy applications may require the use of radioactivity and usually rely upon subjective determination of the results. We have developed two competitive quantitative assays that use an enzyme-linked, amplicon hybridization assay (ELAHA) to detect the products of PCR-amplified regions of transgene from cells transduced with Moloney murine leukemia virus vectors. The quantitative assays (PCR-ELAHA) proved to be simple, rapid, and sensitive, avoiding the need for Southern hybridization, complex histochemical stains, or often subjective and time-consuming tissue culture and immunofluorescence assays. The PCR-ELAHA systems can rapidly detect proviral DNA from any retroviral vector carrying the common selective and marker genes neomycin phosphotransferase and green fluorescent protein, and the methods described are equally applicable to other sequences of interest, providing a cheaper alternative to the evolving real-time PCR methods. The results revealed the number of copies of retrovector provirus present per stably transduced cell using vectors containing either one or both qPCR targets.


Assuntos
Técnicas de Transferência de Genes , Vetores Genéticos , Reação em Cadeia da Polimerase/métodos , Retroviridae/genética , Transdução Genética , Animais , Eletroforese em Gel de Ágar , Marcadores Genéticos , Proteínas de Fluorescência Verde , Humanos , Canamicina Quinase/biossíntese , Cinética , Vírus da Leucemia Murina/genética , Proteínas Luminescentes/biossíntese , Modelos Genéticos , Provírus/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA